EVE BIO

Serial Number 97782979
654

Registration Progress

Application Filed
Feb 6, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

EVE BIO

Basic Information

Serial Number
97782979
Filing Date
February 6, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
654
Status Date
Oct 20, 2025
Application
Pending
Classes
042

Rights Holder

EVE BIO, LLC

16
Address
4020 STIRRUP CREEK DRIVE, SUITE 113
DURHAM, NC 27703

Ownership History

Convergent Research, LLC

Original Applicant
16
Cambridge, MA

EVE BIO, LLC

New Owner Before Publication #1
16
DURHAM, NC

Legal Representation

Attorney
George Lyons, III

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

36 events
Date Code Type Description Documents
Oct 20, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 19, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Apr 19, 2025 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Mar 3, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 24, 2025 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 9, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 9, 2024 ALIE A ASSIGNED TO LIE Loading...
Oct 29, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 29, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 29, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 29, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 18, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Sep 18, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Sep 18, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 28, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 28, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 28, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 1, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 1, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 1, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Apr 17, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 22, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 22, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 22, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 18, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Jan 18, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Oct 18, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 18, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 18, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 10, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 10, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 10, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 24, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of mapping and cataloging interactions between drugs and proteins; Research and development in the field of proteins, protein-based drug development and repurposing, drug-protein interactions, research data about proteins to advance knowledge, development and repurposing of drugs; Research and development in the field of mapping and cataloging interactions between drugs and proteins, namely generating research results in the form of a novel raw dataset cataloging and quantifying interactions between drugs and proteins and providing access to raw dataset catalog online for use by academic, government, foundation and corporate researchers; Think tank services in the nature of scientific consultation services in the field of studying proteins; Think tank services in the nature of scientific consultation services in the field of innovations to prolong and improve the quality of life; Think tank services in the nature of scientific consultation services in the field of application of research findings to practical applications; none of the foregoing relating to providing software or software services; none of the foregoing for providing temporary use of nondownloadable computer software for the use in viewing, managing, organizing, aggregating, analyzing, displaying, and reporting medical, health and wellness data collected via medical devices and sensors; none of the foregoing for providing temporary use of nondownloadable computer software for wireless data communication for receiving, processing, transmitting, aggregating, analyzing, and displaying information relating to medical or health conditions; none of the foregoing for providing temporary use of nondownloadable computer software to collect, analyze, aggregate, manage, report, and transmit patient's medical and health data locally and over a network

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
BIO